Medicine and Dentistry
Base
11%
Cohort Analysis
16%
Collecting Duct
18%
Consultation
10%
COVID-19
16%
Cystic Fibrosis
100%
Cystic Fibrosis Transmembrane Conductance Regulator
47%
Disorders of Calcium Metabolism
7%
Early Intervention
16%
Health Care
6%
Ivacaftor
27%
Lumacaftor
21%
Management of Cystic Fibrosis
20%
Metabolic Alkalosis
12%
Patient with Cystic Fibrosis
29%
Patient-Reported Outcome
16%
Pendrin
16%
Remote Sensing
10%
Secretin
20%
Secretion (Process)
13%
Sodium Bicarbonate
16%
Solid Organ Transplantation
16%
Tezacaftor
23%
Urinary System
14%
Pharmacology, Toxicology and Pharmaceutical Science
Aciduria
16%
Base
17%
Biological Marker
6%
Cystic Fibrosis
66%
Cystic Fibrosis Transmembrane Conductance Regulator
30%
Dicarbonate
33%
Disease
6%
Ivacaftor
23%
Secretin
14%
Tezacaftor
23%
Biochemistry, Genetics and Molecular Biology
Base Excess
12%
Cystic Fibrosis
50%
Cystic Fibrosis Transmembrane Conductance Regulator
50%
Disorders of Calcium Metabolism
9%
Ivacaftor
18%
Pendrin
6%
Secretion (Process)
16%